NADH, Nicotinamide adenine dinucleotide reduced form, disodium salt
Sipariş numarası: M6056.0001
Shipping: shipped at RT, stored at -20°CCAS-Nr: 606-68-8
Teslim süresi yaklaşık. 5 iş günü
Fiyatlar artı KDV artı nakliye maliyetleri
Synonym: β-DPNH; DPNH; Diphosphopyridine nucleotide, reduced form; beta-NADH disodium salt hydrate, reduced.
Substrate for the reduction of oxaloacetate and for the reduction of pyruvate
Composition of the buffer for the reduction of oxaloacetate: 30mM potassium phosphate pH7.5, 0.5mM oxaloacetate, 0.1mM NADH, 20mM KCl, 5mM MgCl2.
Composition of the buffer for the reduction of pyruvate: 10 mM MOPS pH6.1, 10mM Na-pyruvate, 100mM Na2CO3, 0.1mM NADH, 5mM MgCl2.
Also available from Genaxxon: M6058 NADPH tetrasodium salt, min. 98% >.
Technische Daten:
Specifications:
Assay (enzymatic): min. 95.0%
Appearance: White to light-yellow crystalline powder
Water (K.F.): max. 8.0%
Chemical formula: C21H27N7Na2O14P2
MW = 709.41 g/mol (anhydrous)
A 250nm/A 260nm (pH10): 0.82 +/- 0.03
A280nm/A260nm (pH10): 0.23 +/- 0.02
Sicherheits Hinweise / Safety
Klassifizierungen / Classification
EC-Nr: 210-123-3CAS-Nr: 606-68-8
eclass-Nr: 34-16-05-27
Dokumente - Protokolle - Downloads
Hier finden Sie Informationen und weiterführende Literatur zu NADH, Nicotinamide adenine dinucleotide reduced form, disodium salt. Für weitere Dokumente (Zertifikate mit weiteren Lotnummern, Sicherheitsdatenblätter in anderer Sprache, weitere Produktinformationen) wenden Sie sich bitte an Genaxxon biosience unter: info@genaxxon.com oder Tel.: +49 731 3608 123.
